Effects of Polyphenol Containing Antioxidants on Oxidative Stress in Diabetic Patients

Sponsor
Yeditepe University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT00682149
Collaborator
(none)
120
1
2
5
23.9

Study Details

Study Description

Brief Summary

There has been an increase in the prevalance of type 2 diabetes in developed countries in recent years. The major contributing factors have been genetic predisposition, environmental factors, and unhealthy eating habits and stress. Adverse effects on cardiovascular and renal systems after prolonged hyperglycemia bring serious burden to patients, to their families and to the society.

Oxidative stress has been defined as the imbalance between the production of reactive oxygen molecules and antioxidant protective molecules. It has been claimed that oxidative stress that the organism is exposed to and disturbance in anti-oxidant mechanisms have been important in the initiation of diabetes and its complications. Malondialdehyde is the final product of lipid peroxidation and it is an aldehyde as well. It has been accepted that malondialdehyde has been a biomarker in measuring oxidative stress.

Type 2 diabetic people who are between 40 -65 years of age will be the subjects of our study. The levels of fasting glucose, HbA1c, LDL, triglyceride, AST and ALT and also malondialdehyte, hydrogen peroxide and oxidative stress will be determined in patients blood after making them consume a 1500 calory standard diet for 2 weeks, The patients will be randomly divided into two grouos at the end of the two weeks. Group 1 will take placebo in addition to the diet, Group 2 will receive polyphenol containing capsules with pomegranate extract (500 mg), green tea extract (300 mg) and a little bit of (60 mg) vitamin C for three months. At the end of three months the measurement of biochemical parameters will be repeated.

Patients with cardiac, renal, liver disease and smokers will be excluded from the study.

Patients in both groups will have a diet rich in vegetables, three servings of fruit, maximum three slices of bread with a total calory of 1500.

In addition to these, both groups will have a weekly aerobic exercise regimen of 150 minutes conducted after breakfast.

The biochemical results of the two groups will be compared at the end of the experiment and they will be statistically evaluated.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: PomGT (500 mg pomegranate extracts, 300 mg green tea and 60mg vitamin C)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Effects Polyphenol Containing Antioxidants on Oxidative Stress in Diabetic Patients
Study Start Date :
May 1, 2008
Anticipated Primary Completion Date :
Jul 1, 2008
Anticipated Study Completion Date :
Oct 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Group 1

We planned to compare a study group of 60 subjects with a placebo group of 60 subjects

Dietary Supplement: PomGT (500 mg pomegranate extracts, 300 mg green tea and 60mg vitamin C)
1 tablet/day for 3 months
Other Names:
  • Comilac PomGT tablets
  • Active Comparator: Group 2

    We planned to compare a study group of 60 subjects with a placebo group of 60 subjects

    Dietary Supplement: PomGT (500 mg pomegranate extracts, 300 mg green tea and 60mg vitamin C)
    1 tablet/day for 3 months
    Other Names:
  • Comilac PomGT tablets
  • Outcome Measures

    Primary Outcome Measures

    1. Amelioration of antioxidative capacity in diabetic patients by polyphenol containig antioxidants [3 months]

    Secondary Outcome Measures

    1. treatment of type 2 diabetes by polyphenol containing antioxidants [3 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Type 2 diabetic patients between 40-65 years of age will be eligible for the study
    Exclusion Criteria:
    • Patients with cardiac, renal, liver disease and smokers will be excluded from the study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sisli Etfal Education and Research Hospital Istanbul Turkey

    Sponsors and Collaborators

    • Yeditepe University Hospital

    Investigators

    • Principal Investigator: Aysen Fenercioglu, Assist Prof. Dr., Yeditepe University Medical Faculty, Family medicine Department

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00682149
    Other Study ID Numbers:
    • DM2-AOC
    First Posted:
    May 22, 2008
    Last Update Posted:
    May 22, 2008
    Last Verified:
    May 1, 2008

    Study Results

    No Results Posted as of May 22, 2008